Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of trastuzumab in haemodialysis.
Gori S, Foglietta J, Lunardi G, Inno A, Cardinali B, Millo E, Del Mastro L, Nunzi EG, Crinò L. Gori S, et al. Among authors: crino l. Breast J. 2015 May-Jun;21(3):329-31. doi: 10.1111/tbj.12407. Epub 2015 Mar 19. Breast J. 2015. PMID: 25790224 No abstract available.
Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer.
Gori S, Colozza M, Mosconi AM, Franceschi E, Basurto C, Cherubini R, Sidoni A, Rulli A, Bisacci C, De Angelis V, Crinò L, Tonato M. Gori S, et al. Among authors: crino l. Br J Cancer. 2004 Jan 12;90(1):36-40. doi: 10.1038/sj.bjc.6601485. Br J Cancer. 2004. PMID: 14710203 Free PMC article. Clinical Trial.
Primary and metastatic brain tumors.
Franceschi E, Scopece L, Gori S, Chiari R, Crino L. Franceschi E, et al. Among authors: crino l. Forum (Genova). 2006;14(1):E2. Forum (Genova). 2006. PMID: 16873085
Lung cancer.
Crinò L, Foglietta J, Hamzaj A. Crinò L, et al. J Thorac Oncol. 2007 May;2(5 Suppl):S24-6. doi: 10.1097/01.JTO.0000268637.10332.e3. J Thorac Oncol. 2007. PMID: 17457226 Free article. Review. No abstract available.
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).
Guarneri V, Frassoldati A, Bruzzi P, D'Amico R, Belfiglio M, Molino A, Bertetto O, Cascinu S, Cognetti F, Di Leo A, Pronzato P, Crinó L, Agostara B, Conte P. Guarneri V, et al. Among authors: crino l. Clin Breast Cancer. 2008 Oct;8(5):453-6. doi: 10.3816/CBC.2008.n.056. Clin Breast Cancer. 2008. PMID: 18952561 Clinical Trial.
EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
Gori S, Sidoni A, Colozza M, Ferri I, Mameli MG, Fenocchio D, Stocchi L, Foglietta J, Ludovini V, Minenza E, De Angelis V, Crinò L. Gori S, et al. Among authors: crino l. Ann Oncol. 2009 Apr;20(4):648-54. doi: 10.1093/annonc/mdn681. Epub 2009 Feb 2. Ann Oncol. 2009. PMID: 19188134 Free article.
345 results